The frequency of metabolic syndrome in women with polycystic ovaries at reproductive age and comparison of different diagnostic criteria for metabolic syndrome

Journal of the Turkish German Gynecology Association

Volumn 8, Issue 4, 2007, Pages 402-407

  Çalişkan, Eray ^a   Kiliç, Teoman ^a   Bodur, Harika ^a   Zeteroǧlu, Şahin ^b  

^a KOCAELI UNIVERSITY   (Turkey)

^b MUSTAFA KEMAL UNIVERSITY   (Turkey)

Author keywords

Metabolic syndrome; Polycystic ovary syndrome

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH CARE ORGANIZATION; HUMAN; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; MORBIDITY; OVARY POLYCYSTIC DISEASE; PREVALENCE; RISK ASSESSMENT; WAIST CIRCUMFERENCE;

EID: 38649125866     PISSN: 13090399     EISSN: 13090380     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adults Treatment Panel III): Final Report. Bethesda, MD. National Heart, Lung and Blood Institute; 2002.
2. Report of a WHO consultation. In: Alwan A, King H, eds. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: Word Health Organization, Department of Noncommunicable Disease Surveillance; 1999:1-59.
3. Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientific statement. Circulation 2005; 112:2735-52.
4. Alberti KG, Zimmet P, Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome; a new worldwide definition. Lancet 2005;366:1059-62.
5. Grundy SM. Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation 2002;105:2696-8.
6. McGill HC Jr, McMahan CA, Herderick EE et al. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation 2002;105:2712-8.
7. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
8. Wild RA. Long-term health consequences of PCOS. Hum Reprod Update 2002;8:231-41.
9. Legro RS. Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocrine Rev 2003;24:302-12.
10. Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 1999;84(1):165-9.
11. Glueck CJ, Papanna R, Wang P et al. Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovary syndrome. Metabolism 2003;52(7):908-15.
12. Apridonidze T, Essah PA, Iuorno MJ, Nestler JE. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:1929-35.
13. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356-9.
14. Cheal KL, Abbasi F, Lamendola C et al. Relationship to insulin resistance of the Adult Treatment Panel III diagnostic criteria for identification of the metabolic syndrome. Diabetes 2004;53:1195-200.
15. Skilton MR, Moulin P, Sérusclat A et al. A comparison of the NCEP-ATPIII, IDF and AHA/NHLBI metabolic syndrome definitions with relation to early carotid atherosclerosis in subjects with hypercholesterolemia or at risk of CVD: Evidence for sex-specific differences. doi:10.1016/j.atherosclerosis. 2006.02.019.